プログラム委員会
-
Toshiyoshi Tominaga, PHD Life Science Department, Advisor
SunFlare Co., Ltd, Japan -
Koichi Miyazaki, PHD Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan -
Yi Feng SVP, Medical and Reg Affairs
Fountain Medical Development Ltd., China -
Ari Fujishiro Senior Director, Regulatory Affairs Group, Asia Development Dept., R&D Division
Daiichi Sankyo Co., Ltd., Japan -
Tomohisa Hayakawa, PHD Corporate Officer; Head of BD & PM
EPS International Holdings Co., Ltd., Japan -
Shun Jin, MBA Head – BD & RA
PharmaGend Global Medical Services Pte Ltd, Singapore -
Yoshiko Komuro, PHD Director, Office of Research Administration
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Jessica (Chih Min) Lin, MBA, MSC General Manager of Development Division
Chugai Pharma Taiwan Ltd., Taiwan -
Rie Matsui, RPH Senior Director, Regional Labeling Head for APAC
Pfizer R&D Japan G.K., Japan -
Kosuke Mitsui, MBA, MSC, PMP President & General Manager
Chugai Pharma Science (Beijing) Co., Ltd., China -
Tosei Murase, PHD Associate Manager, Japan-Asia Clinical Development 1, Development
Astellas Pharma Inc., Japan -
Ryuji Nagata, PHD Consultant, Regenerative Medicine Promotion Office
EPS Corporation, Japan -
Minsoo Park
KCGI, Korea, Republic of -
Tetsuomi Takano, RPH Editor-in-Chief
Drug R&D Expert, Japan -
Yoshiaki Uyama, PHD, MS, RPH Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
